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Pseudohypoparathyroidism and Related Disorders
C D . Aurbach, M D *

f d. Note - This overview was originally presented at the
International Symposium on Clinical Disorders of Bone
and Mineral Metabolism, May 9-13,1983. The following
list indicates the presentations given in this session at the
Symposium and the contents ofthe corresponding
chapter in the Proceedings of the Symposium published by
Excerpta Medica. The numbers in parentheses refer to
pages in this volume. Complete information about the
contents of the Proceedings can be found at the back of
this issue.

Molecular basis of pseudohypoparathyroidism. C. Van
Dop and H.R. Bourne (453)
Parathyroid hormone bioactivity in familial pseudohypoparathyroidism type I. J.A. Fischer, C. Nagant de Deuxchaisnes, N. Loveridge, M.A. Dambacher, F. Tschopp, E.
Werder, L. Bitensky, and J. Chayen (459)
Resistance to multiple hormones in pseudohypoparathyroidism: Association with deficient activity of guanine nucleotide regulatory protein. M.A. Levine, R.W.
Downs Jr, and A . M . Speigel (464)
Inherent and acquired resistance to parathyroid hormone in man. J.L.H. O'Riordan, G.N. Hendy, and I.G.
Lewin (469)

1 n 1942, Albright and his associates (1) described for the
first time a syndrome of true hormone resistance, which
they called pseudohypoparathyroidism or Sebright
Bantam syndrome.! The classical syndrome of pseudohypoparathyroidism type 1 encompasses not only clinical
hypoparathyroidism with hypocalcemia and hyperphosphatemia, but also certain associated constitutional features, including short stature, round facies, obesity, tendency to mental retardation, shortening o f t h e metacarpal
and metatarsal bones, and subcutaneous calcifications.
The associated constitutional features have also been
designated Albright's hereditary osteodystrophy (AHO).
The original authors found that the subjects were resistant to exogenous parathyroid hormone when tested by
the phosphaturic response. This test has been replaced
by determining the urinary cyclic AMP response to
exogenous parathyroid hormone. The latter test more
efficiently segregates subjects with classical pseudohypoparathyroidism from normal subjects and from those

with other forms of hypoparathyroidism. Albright and
his associates, and many others through the years since
their original report, proposed a number of hypotheses
to explain the biochemical abnormality and mode of
inheritance of pseudohypoparathyroidism. Among the
hypotheses considered by Albright were end-organ resistance to normally secreted parathyroid hormone, antibodies to parathyroid h o r m o n e , and secretion by parathyroid glands of an abnormal peptide capable of
blocking the actions of parathyroid hormone (PTH).
The findings of Chase, et al (2) of defective production of
cyclic AMP in response to PTH redirected attention to
the concept of end-organ resistance and led to the
hypothesis that pseudohypoparathyroidism represented
a defect in the parathyroid hormone receptor-adenylate
cyclase system accounting for end-organ resistance.
Subsequent investigations have found that the cell
membrane content of the guanyl nucleotide regulatory
protein (G-unit that couples receptor activity to adeny-

t N a m e d aher the Sebright Bantam cock, w h i c h he t h o u g h t was resistant to androgens. Recently, it has been proved that the female tail-feathering pattern in this
variant is not due to resistance to androgens, but rather to an abnormally increased
rate of conversion of androgens to estrogens by the skin of these birds (5).
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late cyclase activity) is deficient in most cases of classical
pseudohypoparathyroidism with A H O (3,4). Many of the
other hypotheses, including antibody to hormone, have
been excluded, but recently the concept of an endogenous inhibitor, presumably an abnormal hormone
secreted by the parathyroid gland capable of blocking
receptors, has once again come under consideration.
Fischer (6) presented data obtained with Chayen to indicate that in the plasma of patients with pseudohypoparathyroidism there is an abnormally high ratio of radioimmunoassayable parathyroid h o r m o n e relative to
bioassayable parathyroid hormone. Moreover, they have
found evidence for inhibitory activity in the plasma of
patients with pseudohypoparathyroidism (7). This evidence was determined by adding parathyroid hormone
to plasma and carrying out bioassays utilizing the in vitro
cytochemical bioassay (CBA) for parathyroid hormone
developed by the Chayen group (8). Nevertheless, considerable amounts of bioactive parathyroid hormone
have been detected by two groups, Fischer, et al (pp. 459
ff.) and O'Riordan, et al (pp. 469), applying the CBA assay
in pseudohypoparathyroidism; and the amounts founci
overlap the normal and hyperparathyroid ranges.
Another point to consider is that in any condition of
excess hormone secretion (primary or secondary hyperparathyroidism) the kidney may develop resistance to
the effects of parathyroid hormone. This effect, discussed by O'Riordan, might be attributable to " d o w n
regulat ion " of parathyroid hormone receptors induced
by high concentrations of circulating hormone. Part of
the hormone resistance in pseudohypoparathyroidism
may be due to this d o w n regulation p h e n o m e n o n . On
the other hand, subjects with pseudohypoparathyroidism adequately treated with vitamin D or infused with
calcium (to suppress PTH secretion) continue to express
the resistance to exogenous parathyroid hormone as
determined by urinary cyclin A M P excretion (2). M o r e over, one totally parathyroidectomized patient with the
disorder persistently displays the urinary cAMP response
defect (2). Patients with hormone resistance in vitamin D
deficiency show a correction of this defect after treatment (O'Riordan, et al, pp. 469 ff.).
Genetics of pseudohypoparathyroidism
In the past, pseudohypoparathyroidism has been c o n sidered a sex-linked disorder. There are few d o c u mented cases of male-to-male transmission; the female:
male sex ratio in the disorder is approximately 2 : 1 ; and
pedigrees of families reported appear compatible with
the sex-linked transmission mode. O n the other hand,
a few families do not fit this pattern; some pedigrees
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seem compatible with autosomal dominant inheritance,
others with autosomal recessive transmission (Van Dop
and Bourne, pp. 453 ff.).
Part of the confusion concerning heredity stems from
the fact that there are too few families with multiple
affected members to allow conclusive analysis of inheritance patterns. Also, different investigators use differing
parameters to examine patterns of heredity; parameters
evaluated include phosphaturia, physiognomy, blood
calcium analyses, urinary cyclic AMP responses, and
assays for guanylnucleotide (G-unit) regulatory component. Another reason for the confusion is that errors in
measured parameters have not uniformly been analyzed
statistically. O n e may arrive at a different conclusion
about genetics usingthe urinary cyclic A M P responseon
the one hand, or G-unit analyses on the other. Utilizing
G-unit analyses. Van Dop and Bourne found evidence
that some families with the disorder may represent
recessive or dominant autosomal patterns of inheritance. They readily admitted, however, that pedigree
analyses reported so far do not rule out X-linked inheritance. Si nee the G-unit is composed of two subunits, it is
possible that the gene controlling one subunit is on the
sex chromosome, and the other subunit could be
represented on an autosomal chromosome. Such a
mechanism might account for apparent diversity in
inheritance. Other possible mechanisms are presented
below. Another puzzling feature of the inheritance pattern in pseudohypoparathyroidism is that deficiency
of the G-unit averages approximately 50% and never
approaches, as found in the cyclymphoma cell mutant,
total deficiency, which in the human organism might be
incompatible with life.
What can one surmise about the biochemical nature of
the disorder: deficiency of G-unit or production of
abnormal f o r m of hormone? It is difficult to postulate
two distinct genetic defects to account for the same
abnormality in any given subject. Moreover, production
of a defective hormone seems unlikely to account f o r t h e
generalized defect in hormone responsiveness described
by Levine, et al (pp. 464 ff.). Perhaps deficiency of the
G-unit, a protein controlling adenylate cyclase in all
tissues, can also influence the nature of the product
secreted by the parathyroid cell, a process also regulated
in part by cyclic AMP. Goltzman (9) has recently described phosphorylated forms of parathyroid hormone.
Phospho-proteins are regulated by protein kinases,
some of which also are controlled by cyclic AMP. If there
was an abnormal distribution of phospho-forms elaborated in pseudohypoparathyroidism due to diminished
production of cyclic AMP in the parathyroid cell, one
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might be able to explain a link between G-unit deficiency and production of parathyroid hormone forms
with varying i m m u n o - to bio-activity. Since cyclic AMP
has been implicated in control of chondrocyte function
(10), it is also possiblethat brachydactyly in pseudohypoparathyroidism is another consequence of deficiency of
the G-unit in the adenylate cyclase complex.
Classically, autosomal dominant gene defects in heterozygotes produce 50% reductions in enzyme activity,
since loss of one of a gene pair yields one half of the
normal complement of protein. Fifty percent loss of
function in genes carried on the X chromosome might
occur in w o m e n due to mosaicism, but in affected men
the loss of function w o u l d be total. This is one of the
problems that makes the postulate of sex linkage in
pseudohypoparathyroidism difficult; how would one
explain thereby male subjects showing 50% of normal
complement of the G-unit? Lessons learned in the study
of thalassemia may be instructive. In certain forms of
beta"*" thalassemia (11), the genomic information is normal, but a mutation in an intron causes a splicing defect
with consequent abnormal processing of pre-mRNA.
The net result is production of significant but reduced
amounts of normal beta hemoglobin chains. Such a splicing defect in biosynthesis of G-unit mRNA in pseudohypoparathyroidism, if localized on the X chromosome,
could account for 50% or greater reduction in complement of the protein and be compatible with sex-linked

inheritance. Studies in thalassemia (11) indicatethatsimilar phenotypic expressions of disease can be caused by
many different types of mutations in the genes responsible for hemoglobin synthesis. Like the G-unit, hemoglobin is composed of two different alpha and beta protein subunits. Different genes normally control synthesis
of each subunit (still other genes control synthesis of
gamma and delta chains, which normally do not operate
post nata lly). Mutations in either of the genes for alpha or
beta chains can cause thalassemia, which may vary in
severity from no discernible clinical effect to life-impairing
disease. Moreover, compensatory synthesis of fetal hemoglobins, not normally synthesized in the adult, can yield
partially effective proteins. Perhaps in pseudohypoparathyroidism will be discovered a similarly remarkable
diversity of genetic defects that would account for
phenotypic expression of the disorder, which also seems
to vary in severity.
Currently, the best single unifying hypothesis to account
for the genetic defect of pseudohypoparathyroidism
with A H O is a deficiency of production of the G-unit.
One must recognize, moreover, that more than one type
of inheritance pattern and gene defect may account for
the phenotype of this syndrome. Ultimate resolution of
these problems depends upon structural determination
of the G-unit protein a n d / o r applications of recombinant DNA technology to elucidate the defect at the
polynucleotide level.
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